Residual immune response towards decellularized homografts may be highly individual
Open accessThe DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
OBJECTIVES: Decellularized homograft valves (DHVs) have shown promising clinical results, particularly in the treatment of congenital heart disease. However, DHV appears to elicit an immune response in a subset of young patients, indicated by early valve degeneration. As the decellularization process is quality controlled for each DHV, we hypothesized that there may be residual immunogenicity within the extracellular matrix of DHV. METHODS: A semi-quantitative dot blot analysis was established to screen for preformed recipient antibodies using secondary anti-human antibodies. Fifteen DHV samples (7 aortic, 8 pulmonary) were solubilized and exposed to serum from 20 healthy controls. RESULTS: The sera from young controls (n = 10, 18–25 years) showed significantly stronger binding of preformed antibodies than sera from older individuals (n = 10, 48–73 years). The difference between the means of arbitrary units was 15.1 ± 6.5 (P = 0.0315). There was high intraindividual variance in the mean amounts of arbitrary units of antibody binding with some healthy controls showing >10 times higher antibody binding towards 2 different DHV. The amount of preformed antibodies bound to DHVs was higher in aortic than in pulmonary DHVs. The mean number of antibody binding (in arbitrary units) was 17.2 ± 4.5 in aortic and 14.5 ± 4.7 in pulmonary DHV (P = 0.27). The amount of preformed antibodies bound to pulmonary DHVs was statistically significantly higher in the sera of healthy males (n = 10) than in the sera of healthy females (n = 10). The mean number of arbitrary units was 17.2 ± 4.2 in male and 11.7 ± 5.3 in female sera (P = 0.036). Antibody binding to aortic DHV was also higher in males, but not significant (18.8 ± 5.0 vs 15.6 ± 4.0). Blood group (ABO) incompatibility between the serum from controls and DHV showed no impact on antibody binding, and there was no age-related impact among DHV donors. CONCLUSIONS: Residual immunogenicity of decellularized homografts appears to exist despite almost complete cell removal. The established dot blot method allows a semi-quantitative assessment of the individual immune response towards extracellular DHV components and potentially the possibility of preoperative homograft matching.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures








Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Several factors influence the host immune response against dECM bioscaffolds. In this regard, decellularization efficiency and applied method, ECM alteration, tissue origin, implantation site, and recipient features are the main factors determining the host immune response against decellularized tissues [48–50].”
From Immunogenicity of decellularized extracellular matrix scaffolds: a bottleneck in tissue engineering and regenerative medicine (2023) · cites this paper as [50]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sexual Dimorphism in Innate Immunity
Jaillon, S., Berthenet, K., & Garlanda, C. (2019) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-017-8648-x · Cited by 639
Human innate immunosenescence: causes and consequences for immunity in old age
Panda, A., Arjona, A., Sapey, E., Bai, F., Fikrig, E., Montgomery, R. R., Lord, J. M., & Shaw, A. C. (2009) · Trends in Immunology · doi:10.1016/j.it.2009.05.004 · Cited by 502 · cited 1×
“responsiveness of the immune system is a well-described phenomenon [26].”
Sahlgren, C., Meinander, A., Zhang, H., Cheng, F., Preis, M., Xu, C., Salminen, T. A., Toivola, D., Abankwa, D., Rosling, A., et al. (2017) · Advanced Healthcare Materials · doi:10.1002/adhm.201700258 · Cited by 315
Clinical Application of Tissue Engineered Human Heart Valves Using Autologous Progenitor Cells
Cebotari, S., Lichtenberg, A., Tudorache, I., Hilfiker, A., Mertsching, H., Leyh, R., Breymann, T., Kallenbach, K., Maniuc, L., Batrinac, A., et al. (2006) · Circulation · doi:10.1161/circulationaha.105.001065 · Cited by 299
Self-citationCebotari, S., Tudorache, I., Ciubotaru, A., Boethig, D., Sarikouch, S., Goerler, A., Lichtenberg, A., Cheptanaru, E., Barnaciuc, S., Cazacu, A., et al. (2011) · Circulation · doi:10.1161/circulationaha.110.012161 · Cited by 219
Self-citationPlatelet microparticles sustain autophagy-associated activation of neutrophils in systemic sclerosis
Maugeri, N., Capobianco, A., Rovere-Querini, P., Ramirez, G. A., Tombetti, E., Valle, P. D., Monno, A., D’Alberti, V., Gasparri, A. M., Franchini, S., et al. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aao3089 · Cited by 211
Emmert, M. Y., Schmitt, B. A., Loerakker, S., Sanders, B., Spriestersbach, H., Fioretta, E. S., Bruder, L., Brakmann, K., Motta, S. E., Lintas, V., et al. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aan4587 · Cited by 184
Decellularized fresh homografts for pulmonary valve replacement: a decade of clinical experience
Sarikouch, S., Horke, A., Tudorache, I., Beerbaum, P., Westhoff-Bleck, M., Boethig, D., Repin, O., Maniuc, L., Ciubotaru, A., Haverich, A., et al. (2016) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezw050 · Cited by 159
Self-citationRegulation of decellularized matrix mediated immune response
Chakraborty, J., Roy, S., & Ghosh, S. (2020) · Biomaterials Science · doi:10.1039/c9bm01780a · Cited by 130 · cited 1×
“Matrikines have been shown to modify host cell activity, which may have an impact on the goal of DHV recellularization with nonimmunogenic recipient cells [24].”
Recellularization of decellularized heart valves: Progress toward the tissue-engineered heart valve
VeDepo, M. C., Detamore, M. S., Hopkins, R. A., & Converse, G. L. (2017) · Journal of Tissue Engineering · doi:10.1177/2041731417726327 · Cited by 117
AFFONSODACOSTA, F., DOHMEN, P., DUARTE, D., VONGLENN, C., LOPES, S., HAGGIFILHO, H., AFFONSODACOSTA, M., & KONERTZ, W. (2005) · European Journal of Cardio-Thoracic Surgery · doi:10.1016/j.ejcts.2004.12.057 · Cited by 100
In vitro Irritation Models and Immune Reactions
Gibbs, S. (2009) · Skin Pharmacology and Physiology · doi:10.1159/000178869 · Cited by 98
Baskett, R. J. F., Nanton, M. A., Warren, A. E., & Ross, D. B. (2003) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/s0022-5223(03)00210-1 · Cited by 89
Boethig, D., Horke, A., Hazekamp, M. G., Meyns, B. P., Rega, F., Puyvelde, J. V., Hübler, M., Schmiady, M., Ciubotaru, A., Stellin, G., et al. (2019) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezz054 · Cited by 81
Self-citationBibevski, S., Ruzmetov, M. M., Fortuna, R. S., Turrentine, M. W., Brown, J. W., & Ohye, R. G. (2016) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2016.07.068 · Cited by 78
Neumann, A., Sarikouch, S., Breymann, T., Cebotari, S., Boethig, D., Horke, A., Beerbaum, P., Westhoff-Bleck, M., Bertram, H., Ono, M., et al. (2014) · Tissue Engineering Part A · doi:10.1089/ten.tea.2013.0316 · Cited by 69
Self-citationDecellularized aortic homografts for aortic valve and aorta ascendens replacement
Tudorache, I., Horke, A., Cebotari, S., Sarikouch, S., Boethig, D., Breymann, T., Beerbaum, P., Bertram, H., Westhoff-Bleck, M., Theodoridis, K., et al. (2016) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezw013 · Cited by 65
Self-citationAllograft Heart Valves: Current Aspects and Future Applications
Lisý, M., Kalender, G., Schenke‐Layland, K., Brockbank, K. G. M., Biermann, A., & Stock, U. A. (2017) · Biopreservation and Biobanking · doi:10.1089/bio.2016.0070 · Cited by 63
Developing a Clinically Relevant Tissue Engineered Heart Valve—A Review of Current Approaches
Nachlas, A. L. Y., Li, S., & Davis, M. E. (2017) · Advanced Healthcare Materials · doi:10.1002/adhm.201700918 · Cited by 62
Kneib, C., von Glehn, C. Q. C., Costa, F. D. A., Costa, M. T. B. A., & Susin, M. F. (2012) · Tissue Antigens · doi:10.1111/j.1399-0039.2012.01885.x · Cited by 48
Translational Challenges in Cardiovascular Tissue Engineering
Emmert, M. Y., Fioretta, E. S., & Hoerstrup, S. P. (2017) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-017-9728-2 · Cited by 42
Early Insight Into In Vivo Recellularization of Cell-Free Allogenic Heart Valves
Sarikouch, S., Theodoridis, K., Hilfiker, A., Boethig, D., Laufer, G., Andreas, M., Cebotari, S., Tudorache, I., Bobylev, D., Neubert, L., et al. (2019) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2019.02.058 · Cited by 42
Self-citationSex and Gender Considerations in Transplant Research: A Scoping Review
Laprise, C., Cole, K. M., Sridhar, V. S., Marenah, T., Crimi, C., West, L. J., Foster, B. J., Pilote, L., & Sapir‐Pichhadze, R. (2019) · Transplantation · doi:10.1097/tp.0000000000002828 · Cited by 39
Late durability of decellularized allografts for aortic valve replacement: A word of caution
Helder, M. R. K., Kouchoukos, N. T., Zehr, K. J., Dearani, J. A., Maleszewski, J. J., Leduc, C., Heins, C. N., & Schaff, H. V. (2016) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2016.03.050 · Cited by 34
Böer, U., Buettner, F. F. R., Schridde, A., Klingenberg, M., Sarikouch, S., Haverich, A., & Wilhelmi, M. H. (2017) · Xenotransplantation · doi:10.1111/xen.12288 · Cited by 32
Self-citationDecellularized Allografts for Right Ventricular Outflow Tract Reconstruction in Children
da Costa, F. D. A., Etnel, J. R. G., Torres, R. R. A., Filho, E. M. B., Torres, R., Calixto, A., & Mulinari, L. (2017) · World Journal for Pediatric and Congenital Heart Surgery · doi:10.1177/2150135117723916 · Cited by 32
Paediatric aortic valve replacement using decellularized allografts
Horke, A., Bobylev, D., Avsar, M., Meyns, B. P., Rega, F., Hazekamp, M. G., Huebler, M., Schmiady, M., Tzanavaros, I., Cesnjevar, R. A., et al. (2020) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezaa119 · Cited by 32
Self-citationBöer, U., Schridde, A., Anssar, M., Klingenberg, M., Sarikouch, S., Dellmann, A., Harringer, W., Haverich, A., & Wilhelmi, M. H. (2015) · The International Journal of Artificial Organs · doi:10.5301/ijao.5000395 · Cited by 31
Self-citationRomeo, J. L. R., Mokhles, M. M., van de Woestijne, P. C., de Jong, P., van den Bosch, A. E., van Beynum, I. M., Takkenberg, J. J. M., & Bogers, A. J. J. C. (2018) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezy265 · Cited by 27
In Search of the Ideal Valve: Optimizing Genetic Modifications to Prevent Bioprosthetic Degeneration
Smood, B. F., Hara, H., Cleveland, D. C., & Cooper, D. K. C. (2019) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2019.01.054 · Cited by 25
Dekens, E., Damme, E. V., Jashari, R., Hoeck, B. V., François, K., & Bové, T. (2018) · Interactive Cardiovascular and Thoracic Surgery · doi:10.1093/icvts/ivy316 · Cited by 13
Self-citationSmart, I., Goecke, T., Ramm, R., Petersen, B., Lenz, D., Haverich, A., Niemann, H., & Hilfiker, A. (2020) · Xenotransplantation · doi:10.1111/xen.12646 · Cited by 8
Self-citation
Cited by
Kasravi, M., Ahmadi, A., Babajani, A., Mazloomnejad, R., Hatamnejad, M. R., Shariatzadeh, S., Bahrami, S., & Niknejad, H. (2023) · Biomaterials Research · doi:10.1186/s40824-023-00348-z · Cited by 316
Strategies for development of decellularized heart valve scaffolds for tissue engineering
Snyder, Y., & Jana, S. (2022) · Biomaterials · doi:10.1016/j.biomaterials.2022.121675 · Cited by 70
Işık, M., Karakaya, E., Arslan, T. S., Atila, D., Erdoğan, Y. K., Arslan, Y. E., Eskizengin, H., Eylem, C. C., Nemutlu, E., Ercan, B., et al. (2023) · Advanced Healthcare Materials · doi:10.1002/adhm.202203044 · Cited by 54
Recent Advances in the Modification and Improvement of Bioprosthetic Heart Valves
Tong, Q., Cai, J., Wang, Z., Sun, Y., Liang, X., Xu, Q., Mahamoud, O. A., Qian, Y., & Qian, Z. (2024) · Small · doi:10.1002/smll.202309844 · Cited by 38
Bobylev, D., Horke, A., Boethig, D., Hazekamp, M. G., Meyns, B. P., Rega, F., Dave, H. H., Schmiady, M., Ciubotaru, A., Eduard, C., et al. (2022) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezac219 · Cited by 34
Self-citation
Metadata
- Authors
- Ebken, J., Mester, N., Smart, I., Ramm, R., Goecke, T., Jashari, R., Böthig, D., Horke, A., Cebotari, S., Tudorache, I., Avsar, M., Bobylev, D., Haverich, A., Sarikouch, S., & Hilfiker, A.
- Affiliations
- Medizinische Hochschule Hannover (DE)
- Clinique Saint Jean (BE)
- Corresponding author
- Sarikouch, Samir
- ORCID
- Venue
- European Journal of Cardio-Thoracic Surgery
- Publisher
- Oxford University Press (OUP)
- Published
- 2020-12-03
- Volume
- 59
- Issue
- 4
- Pages
- 773-782
- ISSN
- 1010-7940 (ISSN-L)
- 1873-734X
- PMC
- PMC8083949
- OpenAlex
- W3127211246
- Cited by
- 29
- References
- 32
- Citations by year
- 2026: 4 · 2025: 6 · 2024: 5 · 2023: 7 · 2022: 6 · 2020: 1
- FWCI
- 3.20
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- European Journal of Cardio-Thoracic Surgery (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Funders
- European Union’s HORIZON 2020 Programme (643597)
- Topics
- Health Sciences › Medicine › Surgery › Tissue Engineering and Regenerative Medicine
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Congenital Heart Disease Studies
- Health Sciences › Medicine › Surgery › Transplantation: Methods and Outcomes
- Keywords
- extracellular matrix, congenital heart disease, aortic valve replacement, pulmonary valve replacement, sex differences, ABO incompatibility, valve degeneration, xenotransplantation, immunosuppression
- MeSH terms
- Aortic Valve, Female, Heart Defects, Congenital, Humans, Immunity, Male, Pulmonary Valve, Transplantation, Homologous, Allografts
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.